| Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma B Dankbar, T Padró, R Leo, B Feldmann, M Kropff, RM Mesters, H Serve, ... Blood, The Journal of the American Society of Hematology 95 (8), 2630-2636, 2000 | 821 | 2000 |
| Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia T Padró, S Ruiz, R Bieker, H Bürger, M Steins, J Kienast, T Büchner, ... Blood, The Journal of the American Society of Hematology 95 (8), 2637-2644, 2000 | 682 | 2000 |
| Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease L Badimon, T Padró, G Vilahur European Heart Journal: Acute Cardiovascular Care 1 (1), 60-74, 2012 | 553 | 2012 |
| Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation V Vaccarino, L Badimon, JD Bremner, E Cenko, J Cubedo, M Dorobantu, ... European heart journal 41 (17), 1687-1696, 2020 | 400* | 2020 |
| Lipoprotein (a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation R Alonso, E Andres, N Mata, F Fuentes-Jiménez, L Badimón, ... Journal of the American College of Cardiology 63 (19), 1982-1989, 2014 | 396 | 2014 |
| Predicting cardiovascular events in familial hypercholesterolemia: the SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study) L Perez de Isla, R Alonso, N Mata, C Fernández-Pérez, O Muñiz, ... Circulation 135 (22), 2133-2144, 2017 | 338 | 2017 |
| C-reactive protein in atherothrombosis and angiogenesis L Badimon, E Peña, G Arderiu, T Padró, M Slevin, G Vilahur, ... Frontiers in immunology 9, 430, 2018 | 318 | 2018 |
| Lipoproteínas, plaquetas y aterotrombosis L Badimón, G Vilahur, T Padró Revista espanola de cardiologia 62 (10), 1161-1178, 2009 | 292 | 2009 |
| Nutraceuticals and atherosclerosis: human trials L Badimon, G Vilahur, T Padro Cardiovascular therapeutics 28 (4), 202-215, 2010 | 279 | 2010 |
| Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia T Padro, R Bieker, S Ruiz, M Steins, S Retzlaff, H Bürger, T Büchner, ... Leukemia 16 (7), 1302-1310, 2002 | 264 | 2002 |
| ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’ T Padro, O Manfrini, R Bugiardini, J Canty, E Cenko, G De Luca, ... Cardiovascular research 116 (4), 741-755, 2020 | 256 | 2020 |
| Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques R Suades, T Padró, G Vilahur, L Badimon Thrombosis and haemostasis 108 (12), 1208-1219, 2012 | 218 | 2012 |
| Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. PH Quax, CM van den Hoogen, JH Verheijen, T Padro, R Zeheb, ... Journal of Biological Chemistry 265 (26), 15560-15563, 1990 | 185 | 1990 |
| Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia RM Mesters, T Padró, R Bieker, M Steins, M Kreuter, M Göner, S Kelsey, ... Blood, The Journal of the American Society of Hematology 98 (1), 241-243, 2001 | 182 | 2001 |
| Coronary heart disease, peripheral arterial disease, and stroke in familial hypercholesterolaemia: insights from the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia … L Pérez de Isla, R Alonso, N Mata, A Saltijeral, O Muñiz, P Rubio-Marin, ... Arteriosclerosis, Thrombosis, and Vascular Biology 36 (9), 2004-2010, 2016 | 175 | 2016 |
| Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma G Bisping, R Leo, D Wenning, B Dankbar, T Padró, M Kropff, C Scheffold, ... Blood, The Journal of the American Society of Hematology 101 (7), 2775-2783, 2003 | 175 | 2003 |
| Role of platelet-derived microvesicles as crosstalk mediators in atherothrombosis and future pharmacology targets: a link between inflammation, atherosclerosis, and thrombosis L Badimon, R Suades, E Fuentes, I Palomo, T Padró Frontiers in pharmacology 7, 293, 2016 | 168 | 2016 |
| Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART) N Mata, R Alonso, L Badimón, T Padró, F Fuentes, O Muñiz, ... Lipids in health and disease 10, 1-7, 2011 | 164 | 2011 |
| Infarction of tumor vessels by NGR-peptide–directed targeting of tissue factor: experimental results and first-in-man experience R Bieker, T Kessler, C Schwöppe, T Padró, T Persigehl, C Bremer, ... Blood, The Journal of the American Society of Hematology 113 (20), 5019-5027, 2009 | 164 | 2009 |
| Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on coronary pathophysiology & microcirculation, ESC working group on thrombosis and the … E Cenko, L Badimon, R Bugiardini, MJ Claeys, G De Luca, C de Wit, ... Cardiovascular research 117 (14), 2705-2729, 2021 | 156 | 2021 |
